Biomarkers in systemic sclerosis: an overview
G Di Maggio, P Confalonieri, F Salton, L Trotta… - Current Issues in …, 2023 - mdpi.com
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by significant
fibrosis of the skin and internal organs, with the main involvement of the lungs, kidneys …
fibrosis of the skin and internal organs, with the main involvement of the lungs, kidneys …
Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach
T Kaniecki, M Hughes, Z McMahan - Expert review of clinical …, 2024 - Taylor & Francis
ABSTRACT Introduction Systemic sclerosis (SSc) is a connective tissue disease with
heterogeneous presentation. Gastrointestinal (GI) complications of SSc are characterized by …
heterogeneous presentation. Gastrointestinal (GI) complications of SSc are characterized by …
Is there a therapeutic role for immunosuppression for gastrointestinal involvement in patients with systemic sclerosis?
ZH McMahan, M Hughes - Rheumatology, 2024 - academic.oup.com
Systemic sclerosis (SSc) is an autoimmune connective tissue disease that involves multi-
organ dysfunction [1]. To date, gastrointestinal (GI) complications of SSc remain highly …
organ dysfunction [1]. To date, gastrointestinal (GI) complications of SSc remain highly …
A multi-national survey to identify clinicians' perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis
G Bandini, A Alunno, FO Pinheiro… - Seminars in Arthritis and …, 2024 - Elsevier
Abstract Objectives Proton Pump Inhibitors (PPIs) are widely used in SSc for
gastroesophageal reflux disease (GERD). However, there is little evidence to support their …
gastroesophageal reflux disease (GERD). However, there is little evidence to support their …
POS1311 A MULTINATIONAL SURVEY INVESTIGATING THE UNMET NEEDS AND PATIENT PERSPECTIVES CONCERNING PROTON PUMP INHIBITORS IN …
G Bandini, A Alunno, FO Pinheiro, C Campochiaro… - 2023 - ard.bmj.com
Background Gastrointestinal (GI) complications are a major cause of morbidity and mortality
in systemic sclerosis (SSc)[1]. Proton pump inhibitors (PPIs) are widely used to treat …
in systemic sclerosis (SSc)[1]. Proton pump inhibitors (PPIs) are widely used to treat …